Positive effect of septimeb™ on mortality rate in severe sepsis: a novel non antibiotic strategy
Journal Title: DARU Journal of Pharmaceutical Sciences - Year 2012, Vol 20, Issue 0
Abstract
Background Septimeb is a new herbal-derived remedy, recently approved for its potential immunomodulatory effects. Regarding the key role of immune system in the pathogenesis of severe sepsis and lack of any standard treatment for improving survival of these patients; we evaluated the effect of Septimeb -as an adjutant to standard treatment-on inflammatory biomarkers and mortality rates in patients with severe sepsis. Methods In this multicenter, randomized, single-blind trial, we assigned patients with severe sepsis and Acute Physiology and Chronic Health Evaluation (APACHE II) score of more than 20 to receive standard treatment of severe sepsis (control group) or standard treatment plus Septimeb. This group was treated with Septimeb for 14 days then followed up for another14 days. APACHE score, Sequential Organ Failure Assessment (SOFA) and Simplified Acute Physiology Score (SAPS) were calculated daily. Blood samples were analyzed for interleukin 2 tumor necrosis factor-α, total antioxidant power, platelet growth factor and matrix metalloproteinase 2. Results A total of 29 patients underwent randomization (13 in control group and 16 in Septimeb group). There was significant difference between the Septimeb and control group in the 14 days mortality rate (18.8% vs. 53.85 respectively, P=0.048). Compared to control group, Septimeb was significantly effective in improving SAPS (P= 0.029), SOFA (P=0.003) and APACHE II (P=0.008) scores. Inflammatory biomarkers didn’t change significantly between the two groups (P>0.05). Conclusion Septimeb reduces mortality rates among patients with severe sepsis and it could be added as a safe adjutant to standard treatment of sepsis.
Authors and Affiliations
Kaveh Eslami, Ata Mahmoodpoor, Arezoo Ahmadi, Mohammad Abdollahi, Koorosh Kamali, Sarah Mousavi, Atabak Najafi, Maryam Baeeri, Hadi Hamishehkar, Leila Kouti, Mohammad Reza Javadi, Mojtaba Mojtahedzadeh
Keywords
Related Articles
- EP ID EP135403
- DOI -
- Views 101
- Downloads 0
Reporting of adverse drug reactions: An exploratory study among nurses in a teaching hospital, Ajman United Arab Emirates
Background and the purpose of the study Adverse drug reactions (ADRs) are important public health problem with significant morbidity, mortality and financial burden on the society. Nurses play important role in medicatio...
Biosimilars; a unique opportunity for Iran national health sector and national pharmaceutical industry
In 1980s, medicines produced through recombinant DNA technology created a novel opportunity for management of several debilitating and life threatening diseases. However, these medicines are very expensive and therefore...
Development and characterization of chitosan-polycarbophil interpolyelectrolyte complex-based 5-flurouracil formulations for buccal, vaginal and rectal application
The present investigation was designed with the intention to formulate versatile 5-flurouracil (5-FU) matrix tablet that fulfills the therapeutic needs that are lacking in current cancer treatment and aimed at minimizing...
Role of Omega-3 fatty acids in preventing metabolic disturbances in patients on olanzapine plus either sodium valproate or lithium: a randomized double-blind placebo-controlled trial
Metabolic and cardiovascular side effects have been noted with the use of second generation antipsychotics (SGAs) and mood stabilizers. Since Omega-3 fatty acids have been known to prevent some cardiovascular risks, this...
Neuroprotective properties of Melissa officinalis after hypoxic-ischemic injury both in vitro and in vivo
Brain ischemia initiates several metabolic events leading to neuronal death. These events mediate large amount of damage that arises after some neurodegenerative disorders as well as transient brain ischemia. Melissa off...